Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,556 | -2,954 | -2,029 | -1,362 | -4,523 |
| Depreciation Amortization | 111 | 85 | 60 | 27 | 427 |
| Other Working Capital | 540 | 350 | 212 | 664 | -140 |
| Other Operating Activity | 911 | 706 | 480 | 241 | 1,438 |
| Operating Cash Flow | $-1,994 | $-1,813 | $-1,278 | $-431 | $-2,799 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,599 | 1,435 | 1,078 | 371 | -9,910 |
| PPE Investments | -2 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $1,597 | $1,435 | $1,078 | $371 | $-9,910 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 100 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 12,578 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -100 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $12,578 |
| Exchange Rate Effect | 71 | -5 | -3 | 1 | 1 |
| Beginning Cash Position | 541 | 541 | 541 | 541 | 671 |
| End Cash Position | 215 | 158 | 339 | 482 | 541 |
| Net Cash Flow | $-326 | $-383 | $-203 | $-59 | $-130 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,994 | -1,813 | -1,278 | -431 | -2,799 |
| Capital Expenditure | -2 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,996 | -1,813 | -1,278 | -431 | -2,799 |